Danilov Lab (@danilovlab) 's Twitter Profile
Danilov Lab

@danilovlab

Professor & Director, Early Phase Therapeutics; Co-Director, Lymphoma Center #CLL #lymphoma, translational scientist @cityofhope. Views my own

ID: 1390914034199764996

linkhttps://www.cityofhope.org/research/hematologic-malignancies-research-institute/ calendar_today08-05-2021 06:18:50

564 Tweet

1,1K Followers

460 Following

EmatoInfo (@ematoinfo) 's Twitter Profile Photo

#ASH24 | Alexey Danilov: epcoritamab monotherapy in patients with R/R #chroniclymphocyticleukemia: results from #CLL expansion and optimization cohorts of Epcore CLL-1

#ASH24 | Alexey Danilov: epcoritamab monotherapy in patients with R/R #chroniclymphocyticleukemia: results from #CLL expansion and optimization cohorts of Epcore CLL-1
Wiley Oncology & Hematology (@wileyonc_hem) 's Twitter Profile Photo

In this article, Andrew Zelenetz, MD, PhD from Memorial Sloan Kettering Cancer Center & Alexey Danilov, MD, PhD from City of Hope discuss when BTK inhibitors & venetoclax should be used as treatment for chronic lymphocytic leukemia: ow.ly/rhcJ50UmBJU MSKHemOncTrials Danilov Lab ASH

In this article, Andrew Zelenetz, MD, PhD from <a href="/MSKCancerCenter/">Memorial Sloan Kettering Cancer Center</a> &amp; Alexey Danilov, MD, PhD from <a href="/cityofhope/">City of Hope</a> discuss when BTK inhibitors &amp; venetoclax should be used as treatment for chronic lymphocytic leukemia: ow.ly/rhcJ50UmBJU

<a href="/MSKHemOncTrials/">MSKHemOncTrials</a>
<a href="/DanilovLab/">Danilov Lab</a>
<a href="/ASH_hematology/">ASH</a>
OncLive.com (@onclive) 's Twitter Profile Photo

Single-agent, subcutaneous epcoritamab generated deep responses in patients with relapsed/refractory chronic lymphocytic leukemia. Danilov Lab City of Hope ASH #ASH24 #lymsm #hematology onclive.com/view/epcoritam…

SWOG Cancer Research Network (@swog) 's Twitter Profile Photo

.SWOG Cancer Research Network S2207 is enrolling patients with relapsed/refractory large B-cell #lymphoma. 3-arm trial adds tazemetostat or zanubrutinib to tafasitamab-lenalidomide. PI: Jennifer Amengual, MD Herbert Irving Comprehensive Cancer Center Columbia Medicine SWOG.org/clinical-trial… #LBCL #lymsm #hematology Lymphoma Research Foundation

.<a href="/SWOG/">SWOG Cancer Research Network</a> S2207 is enrolling patients with relapsed/refractory large B-cell #lymphoma. 3-arm trial adds tazemetostat or zanubrutinib to tafasitamab-lenalidomide. PI: Jennifer Amengual, MD <a href="/columbiacancer/">Herbert Irving Comprehensive Cancer Center</a> <a href="/ColumbiaMed/">Columbia Medicine</a>
SWOG.org/clinical-trial… #LBCL #lymsm #hematology <a href="/lymphoma/">Lymphoma Research Foundation</a>
Danilov Lab (@danilovlab) 's Twitter Profile Photo

Today i am celebrating 5 years since our group moved to City of Hope. I am grateful to the institution where, despite the pandemic, we secured two R01s + many foundation grants, published >70 papers, opened a dozen new ISTs and found amazing colleagues and collaborators.

Binaytara (@binaytara) 's Twitter Profile Photo

Excited to have Tycel Phillips, Dr. Annie Xiao, Dr. Swetha Kambhampati Thiruvengadam of City of Hope, Dr. Javier Munoz from Mayo Clinic, Dr. Naseem Shams Esteghamat (UC Davis Health), and Brad Haverkos from CU Cancer Center to discuss #nonhodgkins #lymphoma at #HemeLA25! Session

Excited to have <a href="/LymphClinician/">Tycel Phillips</a>, Dr. Annie Xiao, Dr. Swetha Kambhampati Thiruvengadam of <a href="/cityofhope/">City of Hope</a>, Dr. Javier Munoz from <a href="/MayoClinic/">Mayo Clinic</a>, Dr. Naseem Shams Esteghamat (<a href="/UCDavisHealth/">UC Davis Health</a>), and <a href="/BradHaverkos/">Brad Haverkos</a> from <a href="/CUCancerCenter/">CU Cancer Center</a> to discuss #nonhodgkins #lymphoma at #HemeLA25! Session
Binaytara (@binaytara) 's Twitter Profile Photo

Calling pharmacists! Join us at #HemeLA25 on Mar 28-29 to explore novel agents and complex drug interactions for better patient outcomes in hematologic malignancy treatment. Register NOW: education.binayfoundation.org/content/dogmas… #OncPharm #Pharmacy UCSF Helen Diller Family Comprehensive Cancer Ctr City of Hope UC Davis Health

Calling pharmacists! Join us at #HemeLA25 on Mar 28-29 to explore novel agents and complex drug interactions for better patient outcomes in hematologic malignancy treatment. Register NOW: education.binayfoundation.org/content/dogmas… #OncPharm #Pharmacy <a href="/UCSFCancer/">UCSF Helen Diller Family Comprehensive Cancer Ctr</a> <a href="/cityofhope/">City of Hope</a> <a href="/UCDavisHealth/">UC Davis Health</a>
Danilov Lab (@danilovlab) 's Twitter Profile Photo

At City of Hope #MCL Program we moved beyond chemotherapy to treat #MCL. Several trials available for newly diagnosed patients: Glofitamab-, Venetoclax- and Nemtabrutinib-based, individualized to patients based on disease genetics, with exciting early data Tycel Phillips

At <a href="/cityofhope/">City of Hope</a> #MCL Program we moved beyond chemotherapy to treat #MCL. Several trials available for newly diagnosed patients: Glofitamab-, Venetoclax- and Nemtabrutinib-based,  individualized to patients based on disease genetics, with exciting early data <a href="/LymphClinician/">Tycel Phillips</a>
VJHemOnc (@vjhemonc) 's Twitter Profile Photo

We're thrilled to bring you some fantastic content from #iwCART25!💉🩸 In an exclusive discussion, Krish Patel, Danilov Lab, and Tycel Phillips share updates on the progress of #CARTCell therapy & bispecific antibodies in #lymphoma: 🎥 ow.ly/6GlJ50VKiT4 #LYMsm #HemOnc

Danilov Lab (@danilovlab) 's Twitter Profile Photo

Founders of Russian Rock DDT defined the brief era of freedom in Russia in the 90s. Now banned from performing in Russia due to their Mission of PEACE. Amazing sound and poignant lyrics which make you ponder on what is happening to all of us. CLASSIC.